Company intelligence / Profile preview

FH Ortho

Ownership: Private
Employees: ~106
Development stage: Other

Overview

Over its six-decade history, FH Ortho has launched numerous innovative orthopedic implants and surgical instruments. Its products are widely used for joint reconstruction and trauma repair. Recent launches include the JARVIS reverse shoulder prosthesis baseplate in the US after FDA clearance in November 2024. Clinical studies such as the "FH ORTHO Shoulder Observatory" collect long-term outcomes data on their devices.

The company was acquired by Olympus Corporation in November 2020 to expand Olympus' minimally invasive orthopedics portfolio.

Therapeutic areas: NeurologyRheumatologyOther
Modalities: DeviceBiologic
Industry: Implantable Medical Devices

Partnerships

Distribution partnerships with specialized distributors worldwide

Beyond the preview

Go deeper on FH Ortho.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FH Ortho.

Explore the full profile